Abstract
A frequent complication of left ventricular assist devices (LVAD) is the LVAD-associated infections (LVADIs). Contamination may occur during initial surgery/admission or at a later time. We studied the clinical manifestations and outcomes of LVADIs depending on the time of the onset. Patients implanted with LVADs at our institution between August 2009 and December 2014 were included. Patients were stratified into 2 groups based on whether the infection occurred early (< 180 days) or late (≥ 180 days) after LVAD implantation. Out of 37 overall LVADI episodes, 16 (43%) and 21 (57%) occurred early or late after device implantation, respectively. Median time to first LVADI was 88 ± 35 vs. 456 ± 187 days between groups. While superficial driveline-related infection was the most common LVADI type for both groups (56 vs. 71%, p = 0.489), driveline drainage was more prevalent in the late group (24 vs. 69%; p = 0.009). Early LVADIs involved more gram-positive flora, mostly Staphylococcus aureus (69 vs. 33%, p = 0.049), whereas late LVADIs involved more gram-negative pathogens, mostly Pseudomonas aueroginosa (25 vs. 57%; p = 0.045). High rates of treatment failure were consistent between groups (88 vs. 71%, p = 0.384). Compared with superficial LVADI, deeper infections were associated with an increase in mortality (13 vs 46%, p = 0.046). We concluded that early onset with likely in-hospital contamination involved more gram-positive flora, whereas late infection involved more gram-negative flora. Regardless of timing, success of antibacterial treatment was dismal, and infection depth correlated with poorer outcomes.
Similar content being viewed by others
References
Spelman D, Esmore D. Ventricular assist device infections. Curr Infect Dis Rep. 2012;14:359–66.
Simon D, Fischer S, Grossman A, et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis. 2005;40:1108–15.
Rose EA, Gelijns AC, Moskowitz AL, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Eng J Med. 2001;345:1435–43.
Hannan MM, Husain S, Mattner F, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transpl. 2011;30:375–84.
Nienaber JJ, Kusne S, Riaz T, et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis. 2013;57:1438–48.
Leuck A. Left ventricular assist device driveline infections: recent advances and future goals. J Thorac Dis. 2015;7:2151–7.
Gordon RJ, Weinberg AD, Pagani FD, et al. Prospective, multicenter study of ventricular assist device infections. Circulation. 2013;127:691–702.
Donahey EE, Polly DM, Vega JD, et al. Multidrug-resistant organism infections in patients with left ventricular assist devices. Tex Heart Inst J. 2015;42:522–7.
Goldstein DJ, Naftel D, Holman W, et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transpl. 2012;31:1151–7.
Moazami N, Milano CA, John R, et al. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. Ann Thorac Surg. 2013;95:500–5.
Anand J, Singh SK, Hernandez R, et al. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2015;149:267– 75,278.e1.
Bhatia N, Voelkel AJ, Hussain Z, et al. Safety and feasibility of induction immunosuppression when driveline infection is an indication for cardiac transplantation. Thorac Cardiovasc Surg. 2015;63:675–83.
Trachtenberg BH, Cordero-Reyes A, Elias B, Loebe M. A review of infections in patients with left ventricular assist devices: prevention, diagnosis and management. Methodist Debakey Cardiovasc J. 2015;11:28–32.
Aburjania N, Sherazi S, Tchantchaleishvili V, Alexis JD, Hay CM. Stopping conventional showering decreases Pseudomonas infections in left ventricular assist device patients. Int J Artif Organs. 2017;40:282–285.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Lehnert, A.L., Hart, A., Brouse, S.D. et al. Left ventricular assist device-related infections: does the time of onset matter?. J Artif Organs 22, 98–103 (2019). https://doi.org/10.1007/s10047-018-1078-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-018-1078-6